Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Plasma cell 2Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 191Anemia, Refractory, with Excess of Blasts 179Myelodysplastic Syndromes 175Leukemia 168Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Neoplasms 121Multiple Myeloma 116Venous Thromboembolism 111Anemia 108Leukemia, Myelomonocytic, Chronic 103Leukemia, Lymphocytic, Chronic, B-Cell 100Myeloproliferative Disorders 99Lymphoma, Non-Hodgkin 97Lymphoma 96Hodgkin Disease 85Thrombocytopenia 84Anemia, Aplastic 79Primary Myelofibrosis 67Lymphoma, Follicular 67Hematologic Neoplasms 63Leukemia, Myeloid, Chronic-Phase 61Lymphoma, Mantle-Cell 59Febrile Neutropenia 59Congenital Abnormalities 59Neoplasms, Plasma Cell 57Leukemia, Myeloid, Accelerated Phase 57Anemia, Refractory 57Leukemia, Myelogenous, Chronic, BCR-ABL Positive 56Blast Crisis 56Burkitt Lymphoma 53

Interventions

ofatumumab 1Lenalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Agammaglobulinemia × Classical hematology × Clear all
NCT01002755 2019-05-07

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
36 enrolled 7 charts
Classical hematologyLymphoidOther hematologic neoplasm

Lymphadenopathy, Agammaglobulinemia, Fatigue, Fever, Lymphocytosis, Paraproteinemias, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡